INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹221 Cr | ₹371 Cr | ₹334 Cr | ₹315 Cr | ₹323 Cr |
What is the latest Total Current Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹221 Cr |
Mar2023 | ₹371 Cr |
Mar2022 | ₹334 Cr |
Mar2021 | ₹315 Cr |
Mar2020 | ₹323 Cr |
How is Total Current Liabilities of INDSWIFT LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹221 Cr | -40.37 | |
Mar2023 | ₹371 Cr | 10.95 | |
Mar2022 | ₹334 Cr | 6.34 | |
Mar2021 | ₹315 Cr | -2.65 | |
Mar2020 | ₹323 Cr | - |
Compare Total Current Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹503.0 Cr | -8.6% | -14.8% | -15% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,293.0 Cr | -1.7% | 5.5% | 5.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹139,692.0 Cr | -5.2% | -4.6% | 49% | Stock Analytics | |
CIPLA | ₹111,807.0 Cr | -4.2% | -2.4% | -3.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,404.0 Cr | 1.6% | 8.4% | 26.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹90,843.0 Cr | -5.5% | -3.4% | -9.4% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -8.6% |
-14.8% |
-15% |
SENSEX | -5.5% |
0.2% |
-1% |
You may also like the below Video Courses